Internal Medicine, Rheumatology · Rock Hill, SC
NPI
1184627317
Since 2005
Specialty
Internal Medicine, Rheumatology
Code 207RR0500X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
744 Arden Ln, Suite 225
Rock Hill, SC, 29732
Phone (803) 329-1660
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.5M
115,021 services
Medicare patients, 2024
612
Average age 75
Drug cost, 2024
$1.0M
5,722 prescriptions
Company payments, 2025
$1,465
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by James M Wilson was code J3262 (injection, tocilizumab, 1 mg), 40,360 times for 11 patients. In total James M Wilson billed 115,021 services in 38 codes, and Medicare paid $1.5M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-10-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J3262 Injection, tocilizumab, 1 mg | Office | 40,360 | 11 | $4.35 | $175K |
| J0897 Injection, denosumab, 1 mg | Office | 25,200 | 273 | $20.42 | $515K |
| J1602 Injection, golimumab, 1 mg, for intravenous use | Office | 21,365 | 28 | $9.04 | $193K |
| J1745 Injection, infliximab, excludes biosimilar, 10 mg | Office | 3,590 | 13 | $24.98 | $90K |
| 99214 Office E&M - Established | Office | 791 | 479 | $82.91 | $66K |
| 86235 Immunoassay | Office | 735 | 101 | $17.57 | $13K |
| 99490 Chronic, Principal, and Transitional Care Management | Office | 715 | 104 | $46.42 | $33K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 504 | 353 | $12.04 | $6,070 |
| 96401 Chemotherapy Administration | Office | 433 | 277 | $47.67 | $21K |
| 96413 Chemotherapy Administration | Office | 352 | 65 | $87.14 | $31K |
| 83516 Immunoassay | Office | 274 | 134 | $11.30 | $3,096 |
| 86431 Immunoassay | Office | 138 | 135 | $5.56 | $767 |
| 82306 Clinical Chemistry | Office | 134 | 126 | $29.01 | $3,887 |
| 96415 Chemotherapy Administration | Office | 107 | 19 | $19.46 | $2,082 |
| 86226 Immunoassay | Office | 105 | 101 | $11.87 | $1,246 |
By year: 2022 $1.8M for 126,003 services; 2023 $1.7M for 132,439 services; 2024 $1.5M for 115,021 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 86235 Immunoassay | 735 | 101 | $17.57 | $13K |
| 83516 Immunoassay | 274 | 134 | $11.30 | $3,096 |
| 86431 Immunoassay | 138 | 135 | $5.56 | $767 |
| 82306 Clinical Chemistry | 134 | 126 | $29.01 | $3,887 |
| 86226 Immunoassay | 105 | 101 | $11.87 | $1,246 |
| 86225 Immunoassay | 105 | 101 | $13.47 | $1,414 |
| 86200 Immunoassay | 96 | 95 | $12.69 | $1,218 |
| 86039 Immunoassay | 76 | 75 | $10.94 | $831 |
| 36415 Venipuncture Blood Collection | 17 | 17 | $8.65 | $147 |
Medicare prescription drug claims, 2024
In 2024, the drug James M Wilson prescribed most often to Medicare patients was Hydroxychloroquine Sulfate, with 1,151 prescriptions and refills. In total James M Wilson wrote 5,722 Medicare prescriptions that cost $1.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydroxychloroquine Sulfate Generic | 1,151 | 2,449 | 268 | $41K |
| Prednisone Generic | 925 | 1,773 | 197 | $5,463 |
| Methotrexate Methotrexate Sodium | 589 | 1,135 | 127 | $15K |
| Allopurinol Generic | 288 | 702 | 76 | $3,500 |
| Tramadol Hcl Generic | 244 | 247 | 37 | $2,042 |
| Leflunomide Generic | 234 | 474 | 62 | $9,320 |
| Alendronate Sodium Generic | 198 | 469 | 60 | $1,644 |
| Azathioprine Generic | 172 | 280 | 39 | $5,854 |
| Meloxicam Generic | 157 | 337 | 46 | $834 |
| Colchicine Generic | 152 | 369 | 45 | $8,205 |
| Sulfasalazine Dr Sulfasalazine | 144 | 293 | 38 | $7,683 |
| Diclofenac Sodium Generic | 135 | 287 | 44 | $2,548 |
| Sulfasalazine Generic | 129 | 283 | 34 | $3,093 |
| Gabapentin Generic | 129 | 191 | 26 | $1,746 |
| Celecoxib Generic | 105 | 217 | 28 | $5,654 |
Brand drugs: - claims; generic drugs: 5,314 claims; opioid claims: 264.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid James M Wilson $1,465 ($1,465 in general payments such as food, travel and fees) from 15 companies. The largest payer was Abbvie Inc. with $348.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 9 | $348 |
| Amgen Inc. AMGN | 25 | $239 |
| Janssen Biotech, Inc. JNJ | 7 | $168 |
| Pfizer Inc. PFE | 8 | $159 |
| Novartis Pharmaceuticals Corporation NVS | 4 | $114 |
| AstraZeneca Pharmaceuticals LP AZN | 4 | $110 |
| GlaxoSmithKline, LLC. GSK | 3 | $78.61 |
| ANI Pharmaceuticals, Inc. ANIP | 2 | $63.72 |
| Radius Health, Inc. | 2 | $42.84 |
| Zimmer Biomet Holdings, Inc. ZBH | 1 | $37 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.